CLINICAL_TRIALS ClinicalTrials.gov record update

Open-label, Non-controlled, Multicenter Long-term Study to Investigate the Safety and Efficacy of Xeomin® (Incobotulinumtoxin A, NT 201) for the Treatment of Spasticity of the Lower Limb(s) or of Combined Spasticity of Upper and Lower Limb in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01905683
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:45.960641+00:00
Published At: 2017-10-27T00:00:00+00:00
Record Updated At: 2017-10-27
Results Posted At: 2017-10-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-10-27"
protocolSection.identificationModule.nctId: "NCT01905683"
protocolSection.identificationModule.officialTitle: "Open-label, Non-controlled, Multicenter Long-term Study to Investigate the Safety and Efficacy of Xeomin\u00ae (Incobotulinumtoxin A, NT 201) for the Treatment of Spasticity of the Lower Limb(s) or of Combined Spasticity of Upper and Lower Limb in Children and Adolescents (Age 2 - 17 Years) With Cerebral Palsy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-10-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.